Study identifier:D3461R00058
ClinicalTrials.gov identifier:NCT06046534
EudraCT identifier:N/A
CTIS identifier:N/A
ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated with Anifrolumab in the Early Access Programs.
Systemic Lupus Erythematosus
N/A
No
-
All
37
Observational
18 Years - 130 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jun 2024 by AstraZeneca
AstraZeneca
CernerEnviza / Oracle
No locations available
Arms | Assigned Interventions |
---|---|
Cohort SLE patients who participated in the anifrolumab EAPs (AMANA or ATUc). | - |